HANSOH PHARMA(HK:03692) 智通财经网·2026-01-27 01:53Core Viewpoint - Hansoh Pharmaceutical (03692) has seen its stock price decline over 5%, currently trading at HKD 38.48 with a transaction volume of HKD 69.45 million [1] Group 1: Financial Actions - The company announced a proposal to issue zero-coupon convertible bonds worth HKD 4.68 billion, maturing in 2033, with a conversion price of HKD 57.39, representing a premium of approximately 42.62% over the previous trading day's closing price [1] - The expected net proceeds from the bond issuance are approximately HKD 4.64 billion [1] Group 2: Use of Proceeds - About 65% of the proceeds will be allocated for drug research and development and licensing [1] - Approximately 25% will be used for the construction of new research and development centers and production lines, as well as upgrading existing facilities [1] - The remaining 10% will be designated for working capital and other general corporate purposes [1]